Consistent with this notion, PD-L1-positive cells in the tumor parenchyma of desmoplastic melanomas is highly associated with an increased CD8 density in the tumor invasive margin, that contribute substantial clinical benefits of anti-PD-1/PD-L1 therapy (50). This evidence concerns the gene CD274 and neoplasm.